Food industry asks for exemptions to trans fat phase out
Shortening, pie crusts, brownies and microwave popcorn may be partially exempt from a government phase out of artificial trans fats—if the food industry gets its way.
Aug 6, 2015
0
10
Shortening, pie crusts, brownies and microwave popcorn may be partially exempt from a government phase out of artificial trans fats—if the food industry gets its way.
Aug 6, 2015
0
10
Mylan NV said Wednesday that it received European regulatory approval to move forward with its proposed buyout of Perrigo Co., which has resisted repeated overtures.
Jul 29, 2015
0
8
Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
Jul 27, 2015
0
9
New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development ...
Jul 13, 2015
0
29
The drug industry's decade-spanning search for a female equivalent to Viagra took a major step forward Thursday, as government experts recommended approval for a pill to boost sexual desire in women.
Jun 4, 2015
0
61
Government policies that support UK pharmaceutical science and enhance export income are costing the NHS millions and undermine the National Institute for Health and Care Excellence. In an essay published today by the Journal ...
Apr 29, 2015
0
9
A new study released today found that drugs used to treat multiple sclerosis have soared in price in the past two decades, in some cases more than 700 percent, even though newer drugs have come to the market - a process that ...
Apr 24, 2015
0
499
The food industry is likely to find a receptive Congress come January in its fight against mandatory labeling of genetically modified foods.
Dec 10, 2014
0
0
(HealthDay)—Some food labels may not reliably list all possible food allergens, according to the U.S. Food and Drug Administration. The agency added that these "undeclared allergens" are the leading cause of FDA-requested ...
Oct 29, 2014
0
0
Development of new drugs for treatment of disease is an expensive, time-consuming and labour-intensive effort for both pharmaceutical companies and academics. For the past 15 years, "cost per approval" of new drugs has increased ...
Oct 28, 2014
0
0